Search Results

Seres Therapeutics.

• Authors : Park, Alice (AUTHOR); Dickstein, Leslie (AUTHOR); Espada, Mariah (AUTHOR)

Subjects: BACTERIAL spores; CLOSTRIDIOIDES difficile; ORAL drug administration

• Source: TIME Magazine. 7/3/2023, Vol. 202 Issue 1/2, p69-69. 1p. 1 Color Photograph.

Record details

Encouraging final trial results for Iressa tablets in use on lung cancer patients.

Subjects: LUNG cancer; ORAL drug administration; ONCOLOGYUNITED StatesASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN

• Source: PharmaWatch: Cancer. July 2004, Vol. 3 Issue 7, p10-11. 2p.

Record details

Zydus Lifesciences, Sun Pharma sign licensing agreement for co-marketing of Desidustat.

Subjects: CONTRACTS; LICENSE agreements; CHRONIC kidney failureINDIA

• Source: Ace Analyser: Company News; 10/30/2023, pN.PAG-N.PAG, 1p

Record details

Zydus Lifesciences surges on signing licensing agreement with Sun Pharma for co-marketing of Desidustat.

Subjects: CONTRACTS; LICENSE agreements; CHRONIC kidney failureINDIA

• Source: Ace Analyser: Company News; 10/30/2023, pN.PAG-N.PAG, 1p

Record details

Laurus Labs gains on getting USFDA's tentative approval for Oral Dispersible Film Dolutegravir.

Subjects: DRUG approval; ORAL drug administration; DOLUTEGRAVIRUNITED States. Food & Drug Administration

• Source: Ace Analyser: Company News; 5/3/2023, pN.PAG-N.PAG, 1p

Record details

Laurus Labs gets USFDA's tentative approval for Oral Dispersible Film Dolutegravir.

Subjects: DRUG approval; ORAL drug administration; DOLUTEGRAVIRUNITED States. Food & Drug Administration

• Source: Ace Analyser: Company News; 5/2/2023, pN.PAG-N.PAG, 1p

Record details

Oral Antibiotics --An Overview.

• Authors : Crossen, David K.

Subjects: *PHARMACEUTICAL industry; ANTIBIOTICS; ORAL drug administrationELI Lilly & Co. ELI Lilly & Co. ELI Lilly & Co. LLY

• Source: Black Book - Eli Lilly & Company (1985). 1985, p20-22. 3p. 1 Chart.

Record details

R&D Update -- Other Cancers.

Subjects: DRUG development; CANCER treatment; ORAL drug administrationUNITED States

• Source: PharmaWatch: Cancer; February 2003, Vol. 2 Issue 2, p11-16, 5p

Record details

Celltech gains EU acceptance for review for oral narcolepsy drug Xyrem.

Subjects: DRUGS; ORAL drug administration; NARCOLEPSYCELLTECH Group PLC CELLTECH Group PLC CELLTECH Group PLC CLL; EUROPEAN Union

• Source: PharmaWatch: Biotechnology. May 2004, Vol. 3 Issue 5, p15-15. 1p.

Record details

Roxane wins approval for Morphine sulfate tablets and oral solution.

Subjects: DRUG approval; ORAL drug administration; MORPHINEUNITED StatesROXANE Laboratories Inc. ROXANE Laboratories Inc. ROXANE Laboratories Inc. 058839929 ; UNITED States. Food & Drug Administration

• Source: PharmaWatch: CNS. Sep2008, Vol. 7 Issue 9, p15-15. 1/5p.

Record details